Back to search
Oligometastatic Prostate Cancer (OMPC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Oligometastatic Prostate Cancer (OMPC) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Oligometastatic Prostate Cancer (OMPC) trials you may qualify forThe purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostat…
The goal of this clinical trial is to learn whether an experimental vaccine called pTVG-HP ("vaccine" or "DNA vaccine"), combined with a drug called nivolumab c…
Prostate cancer represents the second most common malignancy in men worldwide. Oligometastatic prostate cancer (OMPC), defined as a transitional state between l…
The TA-P-OLIM Study (Percutaneous Thermo-Ablation of Prostate Cancer OligoMetastasis) is a prospective, interventional phase II study designed to evaluate the f…